论文信息 - A37 N-803 Plus Nivolumab for Advanced or Metastatic Non-Small Cell Lung Cancer: Update on Phase II Experience of Combination PD1 Blockade with an IL-15 Superagonist - 字舞流文

A37 N-803 Plus Nivolumab for Advanced or Metastatic Non-Small Cell Lung Cancer: Update on Phase II Experience of Combination PD1 Blockade with an IL-15 Superagonist

V. Velcheti | M. Rubinstein | William L. Redmond | J. Lee | A. Rock | C. Coggins | M. Patel | C. Kreig | L. Macpherson | John M. Wrangle | M. Sweiderska-syn